Table 5.
Standardized mean difference of the HADS scores for depression in PCOS patients and healthy controls.
| Study (Year) Country |
Number of Cases | Age (Years) (Mean ± SD) |
HADS-D Score (Mean ± SD) |
SMD (Hedge’s g) |
Citation |
|---|---|---|---|---|---|
| Altuntaş (2022) Turkey |
Study group—167 | 25.87 ± 5.64 | 6.61 ± 3.99 | 0.422 | [6] |
| Control—73 | 27.25 ± 5.85 | 4.99 ± 3.41 | |||
| Karsten (2021) Netherlands |
Study group—73 | 34.1 ± 4.1 | 8.2 ± 3.7 | 0.233 | [7] |
| Control—100 | 35.1 ± 3.7 | 7.4 ± 3.2 | |||
| Barry (2011) UK |
Study group—76 | 28.8 ± 4.81 | 4.88 ± 1.98 | 1.052 | [37] |
| Control—49 | 35.12 ± 4.37 | 2.76 ± 2.04 | |||
| Cirik (2016) Turkey |
Study group—101 | 24.44 ± 4.23 | 7.0 ± 4.0 | 0.286 | [45] |
| Control—49 | 26.29 ± 5.17 | 6.0 ± 2.0 | |||
| Sukhapure (2022) New Zealand |
Study group—33 | 29.24 ± 6.81 | 4.82 ± 4.0 | 0.492 | [47] |
| Control—41 | 29.29 ± 8.62 | 3.0 ± 3.36 | |||
| Dag (2017) Turkey |
Study group—53 | 22.69 ± 4.54 | 5.47 ± 2.97 | 0.070 | [49] |
| Control—38 | 21.34 ± 2.12 | 5.23 ± 3.96 |
Pooled SMD (Hedge’s g): 0.421, I2 = 67%; Q = 15.30, p = 0.01.